HYFT

MindWalk Holdings Corp. Stock Price

NasdaqCM:HYFT Community·US$90.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author
Create a narrative

HYFT Share Price Performance

US$1.81
1.22 (207.82%)
63.8% undervalued intrinsic discount
US$5.00
Fair Value
US$1.81
1.22 (207.82%)
63.8% undervalued intrinsic discount
US$5.00
Fair Value
Price US$1.81
AnalystHighTarget US$5.00
AnalystConsensusTarget US$4.00
AnalystLowTarget US$3.00

HYFT Community Narratives

AnalystHighTarget·
Fair Value US$5 62.6% undervalued intrinsic discount

AI Platforms Will Revolutionize Personalized Biologics And Computational Discovery

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AnalystConsensusTarget·
Fair Value US$4 53.3% undervalued intrinsic discount

AI-Driven Discovery Will Advance Biologic Drug Development

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AnalystLowTarget·
Fair Value US$3 37.7% undervalued intrinsic discount

Margin Pressures Will Intensify Yet AI Progress Will Stabilize

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent HYFT News & Updates

MindWalk Holdings Corp. Key Details

CA$25.2m

Revenue

CA$11.1m

Cost of Revenue

CA$14.1m

Gross Profit

CA$44.2m

Other Expenses

-CA$30.1m

Earnings

Last Reported Earnings
Jul 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.65
Gross Margin
55.80%
Net Profit Margin
-119.45%
Debt/Equity Ratio
0%

MindWalk Holdings Corp. Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

4 Risks
1 Reward
View Full Analysis

About HYFT

Founded
1983
Employees
92
CEO
Jennifer Bath
WebsiteView website
www.mindwalkai.com

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Market Insight

Header cover image

📈 Markets Break Records: Q3 2025 in Review, Q4 Outlook Ahead

Richard Bowman avatarRichard Bowman
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Last Week
✨Rare Earths: Tiny Market, Outsized Influence

✨Rare Earths: Tiny Market, Outsized Influence

U.S. Market Performance

  • 7 Days: -2.8%
  • 3 Months: 5.3%
  • 1 Year: 13.4%
  • Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.8%, driven by a decline of 2.5% in the Information Technology sector. In contrast to the last week, the market is actually up 13% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›